Research Study

Oral Micronized Progesterone for Perimenopausal Vasomotor Symptoms
Principal Investigator 
Jerilynn C. Prior

Overview

Body Locations and Systems 
Menopause
ClinicalTrials.gov# 
NCT01464697
Status 
Closed to Recruitment
Study Start/End 
Jun 1, 2011 to Mar 31, 2017
Locations 
Diamond Health Care Centre
Name/Title 
Andrea Cameron, Research Coordinator
Phone 
604-875-5960
Email Address 
andrea.cameron@ubc.ca
Purpose of Study 

The purpose of this study is to test whether an oral micronized progesterone reduces the score, number and severity of hot flushes and night sweats in perimenopausal women. Oral micronized progesterone is molecularly identical to human progesterone, a steroid hormone. It is sold by prescription for use to prevent endometrial cancer in women taking estrogen in menopause. This research study will test whether progesterone reduces perimenopausal hot flushes and night sweats. It will also test whether progesterone improves sleep disturbances and anxiety.

Recruitment is now complete and the data and statistical analysis is now underway. The results of this study will be shared when available.

 

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.